The Schneider Lab for Lung Cancer Research

Welcome to the Schneider Lab!

The Schneider Lab is a basic and translational oncology research group focused on uncovering fundamental drivers of lung cancer growth to advance biological understanding, diagnostics, and therapeutic strategies for patients. Our research lies at the intersection of tumor metabolism, therapeutic resistance, and aging, with the goal of identifying vulnerabilities that can be leveraged to develop new, more effective cancer treatments. Our lab places a strong emphasis on translational relevance, leveraging multi-dimensional patient-derived models to ensure that our discoveries directly inform clinical advances in thoracic oncology. We seek to uncover fundamental principles of how cells utilize metabolic fuels to grow and divide, revealing how tumors exploit metabolic plasticity to persist under stress. These insights are central to understanding how tumors rewire their metabolic programs and to the development of rational, mechanism-based therapeutic strategies that improve outcomes for patients with cancer.

Mission

We are a team of physicians and scientists united by a shared commitment to advancing the understanding and treatment of cancer through scientific discovery. The mission of our laboratory is to develop new therapeutic strategies that improve outcomes for patients with cancer by uncovering the biological principles that govern tumor behavior and therapeutic response. Through an integrative approach bridging basic science and clinical insight, we strive to translate fundamental discoveries into innovative, effective therapies that bring meaningful benefit to patients.

Read more about our research.

Department of Medical Oncology | Division of Molecular and Cellular Oncology | Lowe Center for Thoracic Oncology